|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Pathology, John D. Dingell Veterans Administration Medical Center and Wayne State University Medical School, Detroit, Michigan 48201
| |
ABSTRACT |
|---|
|
|
|---|
Previous studies have shown that adult rat myocytes can be protected from simulated ischemia-reperfusion (I/R) injury by small heat shock proteins (sHSPs). However, to date the cardioprotective effect of sHSPs has not been confirmed in adult myocytes from a large animal species. Left ventricular myocytes from adult dogs were cultured and infected with a replication-deficient adenovirus designed to increase expression of the human form of HSP27. The response to simulated I/R injury was compared using morphologic criteria. Virus-infected myocytes expressed two- to threefold more HSP27 and sustained less injury in response to simulated I/R than control cells (P < 0.001; paired t-test). Canine myocytes can be isolated, cultured, and induced to increase the expression of a foreign protein without significant effects on differentiation and/or viability. Increased expression of HSP27 provides significant protection from simulated I/R injury in adult canine myocytes. Determining the mechanism by which sHSPs protect from lethal cell injury will provide important new insights into the mechanism of irreversible cell injury in adult myocardium.
cytoskeleton; heats shock protein; heart
| |
INTRODUCTION |
|---|
|
|
|---|
SEVERE MYOCARDIAL ISCHEMIA results in irreversible injury of myocytes, which is manifest classically as coagulation necrosis. Despite many years of active research, the exact series of subcellular events underlying the transition from reversible to irreversible injury remains elusive. It is known that certain interventions are capable of modulating or delaying the onset of irreversible injury in experimental model systems such as hypothermia (1, 15), calcium channel blockade (19, 28, 36), and more recently, ischemic preconditioning (16, 26, 29, 32). However, even in experimental model systems, the mechanisms responsible for protection are not fully known. Previous studies have shown that increased expression of heat shock proteins (HSPs), specifically HSP70i, protects ischemic myocardium. Protection with HSP70i against ischemic injury has been shown in a variety of model systems including myogenic cell lines (9), neonatal cardiomyocytes (24), transgenic mice overexpressing HSP70i (23), and whole animals (4, 22). However, heat shock per se (rapidly raising the core temperature of the animal above the normal body temperature) and/or chemical stimulators of HSPs may activate several other members of the large HSP family, which may also be cardioprotective. Such a result would complicate interpretation of the role induction of any specific HSP plays in the mechanism of cardioprotection.
Small HSPs (sHSPs) are a subgroup of the HSP family.
Certain members of the sHSP family, specifically HSP27 and

-crystallin, have several biological characteristics that render
them excellent candidates for playing an important role in
cardioprotection. For example, sHSPs such as HSP27 and

-crystallin are known to exist in measurable quantities in
mammalian myocardium and are induced by oxidative stress, an important
component of ischemia-reperfusion (I/R) injury
(3). In addition, sHSPs are known to function as
"chaperone proteins," proteins that work to facilitate protein folding and translocation at the subcellular level (5).
sHSPs are also known to be associated with cytoskeletal proteins. This association may be important for two reasons. First, HSP27 has been
shown in simple cellular systems to stabilize certain cytoskeletal structures, which in turn have been associated with increased resistance to stress (8, 11). Second, because irreversible ischemic injury in myocardium is thought to involve critical
lesions to the cytoskeletal support system (7, 12, 30,
34), proteins that could bind to and protect these critical
proteins would be predicted to protect against lethal cell injury.
Indeed, sHSPs have been shown to protect against a variety of lethal
injurious insults including hyperthermia, toxic chemical agents,
oxidative injury, and osmotic swelling (2). Martin et al.
(24) reported that increased expression of HSP27 and

-crystallin provided cardioprotection against hypoxic injury in
cultured adult (HSP27) and neonatal (
-crystallin) rat myocytes,
lending further support to the concept that sHSPs play an important
role in lethal ischemic injury.
However, to date no studies investigating the potential cardioprotective role of sHSPs have been conducted in large animal species. Large animal models of myocardial I/R injury are generally considered more applicable to human hearts, because their heart rates and blood pressures are more similar to humans. Furthermore, in vivo studies to date have not resulted in consistent, reproducible overexpression of transgenic proteins. Therefore, it is of considerable interest whether overexpression of potentially cardioprotective proteins, specifically sHSPs, in adult myocytes from a large animal species will result in a cardioprotective effect.
The purpose of the present study was twofold: first, to determine whether isolated adult canine ventricular myocytes could be cultured and infected with a replication-deficient recombinant adenovirus that would result in overexpression of a sHSP without injuring the myocytes; and second, to determine whether increased expression of HSP27 in adult canine myocytes results in a cardioprotective effect in response to simulated I/R injury.
| |
METHODS AND MATERIALS |
|---|
|
|
|---|
All experiments reported here conformed to the standards in the
Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, revised 1985). Adult mongrel dogs (n = 14) of either sex, weighing between
10 and 15 kg, having hematocrits >35, and free from clinically
relevant disease, were anesthetized with 25-35 mg/kg pentobarbital
sodium administered intravenously. Animals were then intubated
and mechanically ventilated (200 ml · kg
1 · min
1;
Harvard respirator) using room air supplemented with 100% oxygen.
After a deep plane of anesthesia was achieved, a left thoracotomy was performed in the fourth intercostal space and the heart was rapidly excised and immediately plunged into ice-cold potassium chloride solution to arrest the heart before transport to the laboratory for isolation of the ventricular myocytes.
Preparation and perfusion of the heart. After excision, the heart was weighed and wet weight was recorded for calculation of perfusion rates. The aortic arch was trimmed and opened, and a small segment of Silastic tubing connected to a three-way stopcock was inserted and tied into the proximal aorta. After cannulation, the position of the cannula was checked to ensure that it was distal to the origin of the coronary ostia. The coronary arteries were flushed with 125 ml of ice-cold calcium-free modified Krebs-Henseleit perfusion buffer (KHB) to ensure that all blood was removed from the coronary arteries. The KHB perfusion buffer contained (in mM) 118 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 KH2PO4, 0.68 glutamine, 11 glucose, 5 Na-pyruvate, 5 NaHCO3, and 20 HEPES; and (in ml/l) 10 basic essential vitamins, 10 minimal essential vitamins, and 10 vitamins.
Isolation of adult canine ventricular myocytes.
After cannulation, the heart with the Silastic cannula attached was
hung on a modified Langendorff-perfusion apparatus and perfused in a
nonrecirculating mode with calcium-free KHB perfusion buffer at 37°C
for 10 min at a flow rate of 1 ml · min
1 · g
1 based on the
recorded heart wet weight. During all perfusion and subsequent
disaggregation steps, the appropriate solutions were continuously
bubbled with 95% O2-5% CO2. During the
calcium-free period, the heart was perfused. After 10 min, the
perfusion solution was changed to calcium-free KHB buffer containing
120 mg of type IV collagenase (Worthington; Freehold, NJ). The
perfusion mode was switched to recirculating and the collagenase
solution was allowed to digest the heart for 25 min (the optimal
duration of collagenase perfusion was determined in a series of pilot
experiments). After 25 min of collagenase perfusion, the heart was
taken down and the left ventricular outflow tract was opened to expose
the endocardial surface of the left ventricular cavity. The endocardium was removed with scissors and the underlying softened left ventricular muscle was harvested, minced with scissors, placed in 80 ml of fresh
calcium-free isolation buffer (37°C), and transferred to a shaking
water bath operating at 37°C. The isolation buffer was a modified KHB
containing (in mM) 80 KCl, 30 KH2PO4, 4 MgSO4, 20 HEPES, 10 glucose, 20 taurine, 5 creatine, 5 succinate, and 0.1% BSA (pH 7.25). The
potassium concentration was raised to maintain electrical arrest of the
tissue to preserve high-energy phosphates (ATP). The partially digested
myocardium was gently agitated in the shaking water bath for 20 min.
During this time, the tissue was continuously bubbled with 95%
O2-5% CO2 gas and was frequently triturated
with a Silastic transfer pipette to encourage further disaggregation of
the myocytes. After 20 min of incubation, the final digest was filtered
through a fine-mesh nylon filter to remove large pieces of collagen and debris.
Purification of myocytes. After completion of the tissue digest, the percentage of rod-shaped cells was increased by gravity-settling the myocytes three times over 2 ml of KHB solution containing 4% BSA. After each settling, the resulting loose pellet was resuspended in fresh KHB buffer containing 0.5% BSA. In pilot experiments, this purification procedure increased the yield of rod-shaped cells ~50% compared with nonsettled cells. After completion of the purification procedure, the cells were pooled and the percentage of rod-shaped cells (vs. round cells) and the overall viability was assessed by mixing an aliquot of the myocytes with Trypan blue (vital dye). A typical isolation yielded ~10 million cells of which 60-80% were rod-shaped. Nearly 100% of the rod-shaped cells were viable (negative stain with Trypan blue), whereas ~95% of the round-shaped cells were nonviable (positive stain with Trypan blue). Therefore, overall viability was approximately 60-80%.
Cell culture.
After isolation and purification of the myocytes, the cells were
cultured on six-well plates (Corning; Corning, NY) for 1 h before
infection. To optimize attachment of the cells, the plates were
precoated with laminin 24 h before the myocyte isolation and kept
in the tissue culture incubator at 37°C until the day of isolation.
After isolation and purification, the myocytes were removed from the
isolation buffer and resuspended in a modified tissue culture media
[containing medium 199 supplemented with 0.2% albumin, 5 mM taurine,
3.0 mM creatine, 3.0 mM carnitine, 10
6 M thyroxine, and
antibiotics (penicillin-streptozotocin and gentamicin) to inhibit
bacterial growth]. After counting the cells using a hemocytometer,
~3.0 ×105 cells were plated in each well of the six-well
plates. Cells were allowed to attach for 1 h and then the media
was changed with fresh culture media to remove unattached myocytes.
Construction of recombinant adenovirus.
The 0.76-kb coding region of the human HSP27 cDNA (provided by Drs. L. Weber and E. Hickey, University of Nevada, Reno, NV) was used to make
the construct. The appropriate fragments were cloned between
the enhancer/promoter of the cytomegalovirus immediate-early genes and
the Simian virus 40 polyadenylation signal of the pACCMV.pLpA shuttle
vector provided by Dr R. Gerard. Replication-deficient adenovirus was
generated through homologous recombination of two plasmids (pJM17, a
bacterial plasmid containing the full-length adenoviral genome, and the
shuttle vector) after cotransfection into E1-transformed human
embryonic kidney 293 cells to produce E1-deleted adenovirus encoding
the appropriate transgene 27. Viral stocks were generated by
infecting confluent HEK-293 cells, harvesting the cells, and
concentrating the cells through CsCl ultracentrifugation. Viral stocks
were then desalted through a Sepharose CL4B (Sigma) column into a
Tris-buffered solution, plaque-titered, aliquoted, and stored at
70°C with 10% glycerol until use.
Experimental protocol. Myocytes were divided into three groups: control, experimental virus-infected, and control virus-infected. The experimental group was infected with replication-deficient adenovirus (all adenoviral constructs were a gift from Drs. Ruben Mestril and Jody Martin, Loyola University, Chicago, IL) containing the cDNA of human HSP27. Another group of myocytes from the same isolation was infected with "empty virus"; a similar strain of replication-deficient adenovirus that did not contain a coding sequence. Finally, one group of myocytes was cultured for 3 days without adenovirus infection. After 3 days of incubation, the three groups of myocytes were each split into two equal halves (three wells from each six-well plate). One half of each plate was used for Western blot analysis of HSP27 protein expression and the other half was used to test for cardioprotection from simulated myocardial I/R injury. The culture media was removed from myocytes to be subjected to simulated ischemia and replaced with new media containing 3.0 mM iodoacetic acid (IAA) to inhibit glycolysis and 3.0 mM amobarbital to inhibit mitochondrial respiration (33). Myocytes incubated in the ischemic buffer were monitored for the development of ischemic contracture as indicated by the assumption of a "square" shape (33). After visual confirmation of the onset of ischemic contracture, cells were "reperfused" with fresh oxygenated culture media without the chemical inhibitors for 10 min and the proportion of live and dead cells was determined using Trypan blue exclusion criteria.
Western blot procedures. Half of each six-well plate not subjected to simulated ischemia was harvested for protein analysis using standard Western blot techniques. Briefly, cells were lysed, placed into a standard sample buffer, and subjected to protein electrophoresis using 7.5% gels. Each well was loaded with an equal amount of protein as determined previously using a standard spectrophotometric protein assay. After electrophoresis, the proteins were transferred to nitrocellulose membranes. Membranes were blocked with 5% nonfat milk in Tween 20 Tris-base sodium for 2 h at room temperature and then incubated overnight at 4°C with a rabbit polyclonal anti-HSP27 primary antibody (at a dilution of 1:1,000). The next day, the membranes were incubated with a goat anti-rabbit IgG (Transduction Laboratories) at a 1:5,000 dilution, and HSP27 protein expression was detected using a chemiluminescence detection system (Amersham; Arlington, IL).
Statistics. Each myocyte isolate generates control and experimental groups, and therefore, each isolate serves as its own control. Statistically significant differences among groups were tested using a paired t-test analysis. In all analyses, a P value of <0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Culture of adult canine ventricular myocytes.
We determined that isolated left ventricular myocytes would represent
the best model to test whether increased expression of HSP27 would be
cardioprotective in canine myocardium. However, to test this hypothesis
requires a selective increase of HSP27 expression in ventricular
myocytes without compromising viability and without inducing increased
expression of HSP27 in other nonmyocyte cells. Because increased
protein expression needs time to develop, the first goal of this study
was to develop a technique to culture adult canine myocytes and keep
them viable for the period of time required to generate increased
expression of a transgenic protein. Using techniques previously
reported to isolate adult rat ventricular myocytes (33,
35), we are routinely able to isolate large numbers of viable
adult canine left ventricular myocytes. Canine myocytes can be kept in
culture for up to 6 days without significant loss of viability or
dedifferentiation (Fig. 1 shows cells
after 3 days of culture). After establishing this technique (details in
METHODS AND MATERIALS), we sought to determine whether
cultured adult canine ventricular myocytes could be directed to
increase a transgenic protein using replication-deficient adenoviral
techniques.
|
Effect of adenoviral infection on adult canine myocytes.
It has been reported that infection of neonatal and adult rat myocytes
with replication-deficient adenoviral constructs results in increased
expression of the transgene (24). However, to date there
have been no reports on whether adenoviral techniques are effective in
increasing protein expression in adult canine ventricular myocytes.
Therefore, one of the primary purposes of this study was to determine
the optimal conditions under which adult canine myocytes can be induced
to increase expression of a transgenic protein. As shown in Fig.
2, using an adenovirus previously shown to result in a robust increase in HSP27 protein expression in neonatal
rat myocytes, infection of adult canine myocytes resulted in a large
increase in myocyte HSP27 content (average two- to threefold vs.
control cells at 3 days). Importantly, the viability of infected
myocytes did not differ significantly from control cells
(Fig. 3). After confirming that
adult myocytes could be successfully induced to increase expression of
HSP27, we sought to determine the optimal dose and time of adenoviral
infection. As shown in Fig. 4, myocytes
infected with 250 multiplicity of infection (MOI) expressed
more HSP27 protein than those infected with 100 MOI. However,
increasing the MOI further to 750 did not result in significantly more
HSP27 expression. Furthermore, we determined that extending the
duration of postinfection culture (at a given MOI) to 6 days did not
result in more HSP27 expression than was present at 3 days (Fig. 4). On
the basis of these results, the remaining experiments were conducted
using myocytes 3 days after infection with adenovirus.
|
|
|
Effect of increased HSP27 expression on response to simulated I/R
injury.
Having established the optimal dose and time course for increased
expression of HSP27, we sought to determine whether increased HSP27 expression would protect isolated myocytes against simulated I/R
injury. Myocytes were infected with adenovirus for 3 days at 250 MOI
and then subjected to I/R. The viability of the myocytes over 3 days of
culture did not differ between control and infected myocytes (89.0 ± 1.5% control vs. 89 ± 5.1% adenoviral infected; P = not significant; Fig. 3). Incubating the myocytes
with inhibitors of both glycolysis (IAA) and mitochondrial respiration
(amytal) simulated I/R injury. From previous studies, it is known that the time course to ischemic contracture (as indicated by the
assumption of a "square" shape vs. the normal rod-shaped
configuration) is variable among individual myocytes, but the
subsequent period of time (from onset of contracture to irreversible
injury) is constant (31). The use of the combination of
IAA and amytal overcomes this problem by accelerating energy depletion
and thereby "synchronizing" the onset of ischemic
contracture. In these experiments, myocytes were monitored for the
onset of contracture after the addition of IAA and amytal. The time
point at which ischemic contracture developed was somewhat
variable (range 12-45 min; mean = 19.16 ± 5.8 SE min;
n = 6) among individual isolates (reflecting the importance of using each isolate as its own control) but was
synchronous for all myocytes on a given culture plate. After the onset
of contracture, myocytes were incubated an additional 20 min with IAA
plus amytal. After 20 min, the ischemic buffer was removed and
control oxygenated culture media was added for 15 min to wash out the
chemical inhibitors and thereby simulate reperfusion. After I/R, 34.4%
of control myocytes were viable using Trypan blue exclusion criteria,
whereas 51.3% of myocytes expressing HSP27 were viable
(n = 6). Myocytes infected with the empty virus were
not significantly different from control uninfected myocytes (data not
shown). Figure 5 summarizes the data and
shows that compared with control myocytes, myocytes expressing HSP27
were protected from simulated I/R injury.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of this study were that 1) adult canine left ventricular myocytes can be isolated and cultured for several days without showing evidence of dedifferentiation or significant loss of viability, 2) cultured adult canine myocytes can be infected with a replication-deficient adenovirus that increases the expression of a transgenic protein without loss of viability or significant alteration in myocyte architecture, and 3) increased expression of the small HSP27 is associated with protection of isolated adult canine myocytes from simulated I/R injury.
Cultured adult canine ventricular myocytes. Several model systems incorporating cultured myocytes have been developed to study various aspects of cardiovascular pathophysiology. Cultured myocytes offer several advantages over whole organ and/or whole animal studies including the ability to study relatively pure populations of myocytes, the ability to precisely control the experimental conditions and the doses of administered pharmacological agents, and the ability to manipulate and measure protein synthesis and production. In addition, cultured myocytes provide an attractive model system for the application of transgenic experimental approaches. For example, to investigate the selective manipulation of targeted intracellular proteins requires that the manipulation occur only in myocytes and not in vascular smooth muscle cell, endothelial cells, or other cellular elements present in whole organs or animals. Furthermore, selective manipulation of intracellular myocyte proteins requires a targeted delivery system. Many proteins exist in large families and physical or chemical upregulation of one family member more often than not results in upregulation of unintended other family members, which complicates interpretation of the resulting data.
To date, however, most models of cultured myocytes have utilized neonatal myocytes or adult myocytes of rodent species, such as mice or rats. The reasons for this are likely related to many variables including the cost and availability of small animals versus larger species, such as dogs. Furthermore, there are important physiological and metabolic differences between small animal species and large animal species (e.g., heart rate, blood pressure, and primary mode of metabolism; i.e., glycolysis vs. oxidative metabolism), which may have an important impact in the study of I/R injury. Therefore, one important aspect of the present study was to develop a model of cultured myocytes utilizing left ventricular myocytes from an adult large animal species, the dog. The results of the present study indicate that adult canine myocytes can be isolated in large numbers and that the resulting myocytes can be placed and maintained in culture for several days without a significant loss of viability or dedifferentiation. Such myocytes are suitable for the study of protein synthesis/degradation, electrophysiology, structure/function studies, and the study of cell injury and/or cellular protection.Infection of canine myocytes with adenovirus. Previous studies have also shown that transgenic proteins can be expressed using different expression techniques ranging from lipafectamine to direct injection into the myocardium. More recent studies have demonstrated that replication-deficient adenoviral constructs can be useful tools in the selective modulation of intracellular myocyte proteins. For example, the study by Martin et al. (24) showed that expression of the small HSP27 (using the virus utilized in the present study) can be significantly increased in cultured neonatal and adult rat myocytes.
The present results confirm and extend these previous studies by showing that a similar, selective increase in intracellular proteins, in this case HSP27, can be achieved in cultured adult canine ventricular myocytes. In the present study, adenovirus infection induced a dose- and time-dependent increase in HSP27 levels in adult canine myocytes (see Fig. 4). Furthermore, the increased expression of HSP27 was not associated with significant toxicity to the myocytes or with a significant alteration in myocyte architecture. To our knowledge, this is the first report of stable transgenic gene expression in isolated adult canine myocytes. The effects of altering other intracellular proteins and/or enzymes could be investigated in canine myocytes using similar techniques.Effect of increased HSP27 expression on the response to simulated I/R. Numerous studies have shown that HSPs, specifically HSP70 and sHSPs such as HSP27, are capable of causing substantial protection from the irreversible injury associated with I/R (2). Protection from I/R injury has been documented in many different model systems ranging from in vitro cell culture to transgenic mice (4, 9, 22-24). However, until recently, most studies have utilized heat shock to increase or induce the expression of HSP. Martin et al. (24) utilized an adenovirus to selectively increase the expression of HSP27, which proved to be protective against simulated I/R injury in adult rat myocytes. The present study was designed to study selective overexpression of HSP27 in adult canine ventricular myocytes. Results show that increased expression of HSP27 results in protection from simulated I/R injury in a separate adult species. The fact that HSP27 has now been shown to protect in two adults species in independent studies further underlines the importance of investigating the mechanism through which sHSPs protect myocytes from I/R injury.
Possible mechanisms of HSP27-induced effect. Many studies have shown that increased expression of HSP results in protection from lethal I/R injury, but the mechanism through which they act remains open to speculation. Stress proteins have the potential to inhibit or reduce lethal injury through many different ways, including inhibition of proapoptotic pathways, increasing expression of antioxidant proteins, inhibiting release of suicide activators of cytochrome c, preventing the destruction of key structural cytoskeletal proteins, or a combinatorial or additive effect (10, 17, 18, 20, 25, 27). Results from recent studies support the notion that sHSPs such as HSP27 may work through many unique, protective pathways. For example, increased expression of HSP27 has been shown to cause an increase in cellular levels of the antioxidant protein glutathione as well as decreased Fas/APO-1-mediated apoptosis (17, 25). On the contrary, reduction of HSP27 expression has been shown to decrease glutathione levels and result in increased rates of apoptosis (17, 25). In addition to affecting apoptotic pathways and antioxidant protein levels, sHSPs have been shown to bind to and reduce the destruction of actin fibers in other cell systems, a function commonly known as "chaperone" (5). Although there is no direct evidence that HSP27 performs a chaperone function in myocytes, it is logical to hypothesize that the chaperone function of sHSPs may also extend to critical cytoskeletal proteins in myocytes. Cytoskeletal proteins are structural proteins that play an important role in maintaining the intact highly ordered structure of the myocyte under normal conditions as well as in response to cellular stress (6). Indeed, evidence that critical lesions develop in the myocyte cytoskeleton before the onset of irreversible injury has existed for many years (6, 7, 12, 30, 34). It is possible that during the early phases of ischemic injury, sHSPs bind to critical cytoskeletal proteins thereby preventing their destruction and delaying the onset of lethal cell injury. If so, then HSP27 could be acting through multiple different cytoskeletal proteins, i.e., talin, dystrophin, vinculin, or spectrin, to accomplish cellular protection.
One of the fundamental biological characteristics of irreversible injury in myocytes is the progressive destruction of the adenine nucleotide pool, which results in exhaustion of cellular high-energy phosphate stores (13, 14). Therefore, it is possible that sHSPs such as HSP27 could produce a cardioprotective effect by binding to critical metabolic proteins and/or enzymes, thereby preventing or delaying destruction of such proteins. In support of this hypothesis, Mestril and colleagues (21) have recently shown that sHSPs can interact with mitochondrial proteins, some of which are important in oxidative phosphorylation. To determine which mechanism HSP27 utilizes to achieve cardioprotection will require additional studies that should include confocal microscopy and/or other techniques designed to determine the subcellular distribution of HSP27 under normal conditions and when its expression is increased. Such studies will provide a starting point for determining which proteins HSP27 may interact with and provide important clues as to ultimate mechanism of cardioprotection. In summary, this study shows that isolated adult canine ventricular myocytes can be isolated and cultured for a period of time necessary to accomplish acute transfection experiments, thereby providing a new model system to study many aspects of myocardial biology including determining the pathways of protection from irreversible cell injury. In addition, the present study shows that isolated adult canine ventricular myocytes can be infected with an adenoviral delivery system and be induced to increase transgenic protein expression severalfold without causing visible modification of the myocytes or causing acute myocyte death. Finally, the present study is the first using adult canine myocytes to show that increased expression of HSP27 is capable of protecting isolated myocytes from irreversible injury secondary to simulated I/R. Future studies will be directed at determining which subcellular proteins HSP27 bind to and ultimately the mechanism of irreversible injury in adult myocytes.| |
ACKNOWLEDGEMENTS |
|---|
The authors are grateful to Marci Alipour for technical assistance.
| |
FOOTNOTES |
|---|
These studies were supported by National Heart, Lung, and Blood Institute Grant HL-59563.
Address for reprint requests and other correspondence: R. S. Vander Heide, Dept. of Pathology, Wayne State Univ. Medical School, 540 East Canfield Ave., Detroit, MI 48201 (E-mail: rvanderh{at}med.wayne.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00660.2001
Received 26 July 2001; accepted in final form 9 November 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Angell, WW,
Rikkers L,
Dong E, Jr,
and
Shumway NE.
Organ viability with hypothermia.
J Thorac Cardiovasc Surg
58:
619-624,
1969.
2.
Benjamin, IJ,
and
McMillan DR.
Stress (heat shock) proteins. Molecular chaperones in cardiovascular biology and disease.
Circ Res
83:
117-132,
1998.
3.
Bennardini, F,
Wrzosek A,
and
Chiesi M.

-Crystallin in cardiac tissue association with actin and desmin filaments.
Circ Res
71:
288-294,
1992.
4.
Currie, RW,
Karmazyn M,
Kloc M,
and
Mailer K.
Heat-shock response is associated with enhanced postischemic ventricular recovery.
Circ Res
63:
543-549,
1988.
5.
Ellis, RJ,
and
vander Vies SM.
Molecular chaperones.
Annu Rev Biochem
60:
321-347,
1991.
6.
Ganote, CE,
and
Armstrong S.
Ischaemia and the myocyte cytoskeleton: review and speculation.
Cardiovasc Res
27:
1387-1403,
1993.
7.
Ganote, CE,
and
Vander Heide RS.
Cytoskeletal lesions in anoxic myocardial injury: a conventional and high voltage electron microscopic and immunofluorescence study.
Am J Pathol
129:
327-344,
1987.
8.
Guay, J,
Lambert H,
Gingras-Breton G,
Lavoie JN,
Huot J,
and
Landry J.
Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27.
J Cell Sci
110:
357-368,
1997.
9.
Heads, RJ,
Latchman DS,
and
Yellon DM.
Stable high level expression of a transfected human HSP70 gene protects a heart-derived muscle cell line against thermal stress.
J Mol Cell Cardiol
26:
695-699,
1994.
10.
Hoshida, S,
Yamashita N,
Oe H,
Fuji H,
Hori M,
Tada M,
and
Kamada T.
Brief myocardial ischemia affects free radical generating and scavenging systems in dogs.
Heart Vessels
8:
115-120,
1993.
11.
Huot, J,
Lambert H,
Lavoie JN,
Guimond F,
Houle F,
and
Landry J.
Characterization of 45-kDa/54 kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat shock protein HSP27.
Eur J Biochem
227:
416-427,
1995.
12.
Iwai, K,
Hori M,
Kitabatake A,
Kurihara H,
Uchida K,
Inoue M,
and
Kamada T.
Disruption of microtubules as an early sign of irreversible ischemic injury. Immunocytochemical study of in situ canine hearts.
Circ Res
67:
694-706,
1990.
13.
Jennings, RB,
Hawkins HK,
Lowe JE,
Hill ML,
Klotman S,
and
Reimer KA.
Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog.
Am J Pathol
92:
187-214,
1978.
14.
Jennings, RB,
Sommers HM,
Smyth GA,
Flack HH,
and
Linn H.
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.
Arch Pathol
70:
68-78,
1960.
15.
Jones, RN,
Reimer KA,
Hill ML,
and
Jennings RB.
Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia.
J Mol Cell Cardiol
14:
123-130,
1982.
16.
Kloner, RA,
Shook T,
Przyklenk K,
Davis VG,
Junio L,
Matthews RV,
Burstein S,
Gibson M,
Poole WK,
Cannon CP,
McCabe CH,
and
Braunwald E.
Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning.
Circulation
91:
37-47,
1995.
17.
Kohno, T,
Yamada Y,
Hata T,
Mori H,
Yamamura M,
Tomonaga M,
Urata Y,
Goto S,
and
Kondo T.
Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells.
J Immunol
156:
4722-4728,
1996.
18.
Kuzuya, T,
Hoshida S,
Yamashita N,
Fuji H,
Oe H,
Hori M,
Kamada T,
and
Tada M.
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia.
Circ Res
72:
1293-1299,
1993.
19.
Lamping, KA,
Christensen CW,
Pelc LR,
Warltier DC,
and
Gross GJ.
Effects of nicorandil and nifedipine on protection of ischemic myocardium.
J Cardiovasc Pharmacol
6:
536-542,
1984.
20.
Liang, P,
and
MacRae TH.
Molecular chaperones and the cytoskeleton.
J Cell Sci
110:
1431-1440,
1997.
21.
Lin, K,
Lin B,
Lian I,
Mestril R,
Scheffler I,
and
Dillmann W.
Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation.
Circulation
103:
1787-1792,
2001.
22.
Marber, MS,
Latchman DS,
Walker JM,
and
Yellon DM.
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.
Circulation
88:
1264-1272,
1994.
23.
Marber, MS,
Mestril R,
Chi SH,
Sayen R,
and
Yellon DM.
Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.
J Clin Invest
95:
1446-1456,
1995.
24.
Martin, JL,
Mestril R,
Hilal-Dandan R,
Brunton LL,
and
Dillmann WH.
Small heat shock proteins and protection against ischemic injury in cardiac myocytes.
Circulation
96:
4343-4348,
1997.
25.
Mehlen, P,
Schulze-Osthoff K,
and
Arrigo AP.
Small stress proteins as novel regulators of apoptosis: heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death.
J Biol Chem
271:
16510-16514,
1996.
26.
Murry, CE,
Jennings RB,
and
Reimer KA.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation
74:
1124-1136,
1986.
27.
Polla, BS,
Kantengwa S,
Francois D,
Salvioli S,
Franceschi C,
Marsac C,
Cossarizza A,
Jacquier-Sarlin MR,
and
Polla BS.
Mitochondria are selective targets for the protective effects of heat shock against oxidative injury: dual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxin.
Proc Natl Acad Sci USA
93:
6458-6463,
1996.
28.
Reimer, KA,
and
Jennings RB.
Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
Lab Invest
51:
655-666,
1984.
29.
Schott, RJ,
Rohmann S,
Braun ER,
and
Schaper W.
Ischemic preconditioning reduces infarct size in swine myocardium.
Circ Res
66:
1133-1142,
1990.
30.
Steenbergen, C, Jr,
Hill ML,
and
Jennings RB.
Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart.
Circ Res
60:
478-486,
1987.
31.
Stern, MD,
Chien AM,
Capogrossi MC,
Pelto DJ,
and
Lakatta EG.
Direct observation of the "oxygen paradox" in single rat ventricular myocytes.
Circ Res
56:
899-903,
1985.
32.
Thornton, JD,
Striplin S,
Liu GS,
Swafford A,
Stanley AWH,
Van Winkle DM,
and
Downey JM.
Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning.
Am J Physiol Heart Circ Physiol
259:
H1822-H1825,
1990.
33.
Vander Heide, RS,
Angelo JP,
Altschuld RA,
and
Ganote CE.
Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes.
Am J Pathol
125:
55-68,
1986.
34.
Vander Heide, RS,
and
Ganote CE.
Increased myocyte fragility following anoxic injury.
J Mol Cell Cardiol
19:
1085-1103,
1987.
35.
Vander Heide, RS,
Rim D,
Hohl CM,
and
Ganote CE.
An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes.
J Mol Cell Cardiol
2:
165-181,
1990.
36.
Vander Heide, RS,
Schwartz LM,
and
Reimer KA.
The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
Cardiovasc Res
28:
1526-1532,
1994.
This article has been cited by other articles:
![]() |
X.-Y. Lu, L. Chen, X.-L. Cai, and H.-T. Yang Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T Cardiovasc Res, August 1, 2008; 79(3): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Szerafin, K. Hoetzenecker, S. Hacker, A. Horvath, A. Pollreisz, P. Arpad, A. Mangold, T. Wliszczak, M. Dworschak, R. Seitelberger, et al. Heat Shock Proteins 27, 60, 70, 90{alpha}, and 20S Proteasome in On-Pump Versus Off-Pump Coronary Artery Bypass Graft Patients Ann. Thorac. Surg., January 1, 2008; 85(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, I. S. Ali, and R. W. Currie Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27 Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H74 - H87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, W. Campbell, and R. S. Vander Heide Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H638 - H647. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion Exp Physiol, July 1, 2005; 90(4): 593 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C Chi and J. S Karliner Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors Cardiovasc Res, February 15, 2004; 61(3): 437 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, T. L'Ecuyer, and R. S. Vander Heide Effect of increased expression of cytoskeletal protein vinculin on ischemia-reperfusion injury in ventricular myocytes Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H911 - H918. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |